WHOOP Hires FDA Advisory Committee Chair as Chief Medical Officer
Dr. Ami Bhatt, a cardiologist and chair of the FDA's digital health advisory committee, joins WHOOP as CMO. What does this mean for the company's direction?
WHOOP just made a significant hire — and this isn't just any appointment. Dr. Ami Bhatt is a cardiologist with over two decades of experience who currently chairs the FDA's advisory committee on digital health. Coming just weeks after WHOOP resolved a dispute with the FDA over blood pressure measurement, the timing is pretty telling. Let's break down what this means.
Who Is Dr. Ami Bhatt
Ami Bhatt is a cardiologist who's spent her career at the intersection of traditional medicine and digital technology. According to WHOOP's press release and reporting from MedTech Dive, she served as Chief Innovation Officer at the American College of Cardiology — one of the most influential cardiology organizations in the world.
But here's the key part: Bhatt currently chairs the FDA's advisory committee on digital health. This committee oversees everything from AI-powered devices to digital mental health tools. In other words — exactly the type of products WHOOP is clearly moving toward.
Why Now
The timing isn't coincidental. WHOOP recently dealt with an uncomfortable situation involving the FDA and blood pressure measurement. If you've been following along, we covered it in our posts on how the case closed and the measurement adjustment. The issue was that WHOOP started offering blood pressure measurement in a way the FDA flagged as problematic. The company eventually adjusted the feature and resolved the dispute.
Now WHOOP is bringing on someone who literally sits on the other side of the table — in the FDA's advisory body. This isn't just a PR move. It's a signal that WHOOP takes the regulatory path seriously and wants to build health features that can withstand scrutiny.
What Will Bhatt Do at WHOOP
According to the press release, Bhatt will connect WHOOP's health features to its broader strategy. WHOOP describes it as building "a bridge between everyday health and clinical care."
Translated from corporate speak: WHOOP wants its data and features to have clinical relevance. Not just "your recovery is 47%, take it easy," but potentially things like:
- Screening for cardiac arrhythmias
- Validated blood pressure measurement (this time with FDA clearance)
- Integration with healthcare providers
- AI-powered health recommendations that hold up to regulatory scrutiny
Whether they pull it off is an open question. But the direction is clear.
From Fitness Tracker to Medical Device
This is a trend I've been watching for a while. WHOOP started as a tool for elite athletes — strain, recovery, sleep. It gradually added features like SpO2 measurement, skin temperature, and then that controversial blood pressure reading.
Hiring Bhatt shows WHOOP is serious about moving into healthcare. It's not just about adding another metric to the app. It's about getting regulatory approval, clinical validation, and trust from the medical community.
For us as users, this could mean two things. First — new health features that carry real weight beyond "interesting number on your screen." Second — possibly longer waits for new features, because FDA approval isn't a sprint; it's a marathon.
For context: Apple got FDA clearance for the EKG feature on Apple Watch in 2018. Since then, it's added atrial fibrillation detection and SpO2 measurement. The whole process took years and significant resources. WHOOP is now signaling it wants to follow a similar path — and hiring someone from the FDA's advisory committee is a logical first step. The difference is that WHOOP doesn't have a display and is betting on continuous monitoring, which might present a different kind of challenge for the FDA.
The Bottom Line
Don't expect a new FDA-approved feature to show up in the app tomorrow. That's not how this works. But hiring Dr. Ami Bhatt is the strongest signal WHOOP could send: we want to be more than a fitness tracker, we want to be a medical device, and this time we're going to do it right.
As a WHOOP user, I'm encouraged. After the blood pressure situation, I had some concerns about whether the company would just keep adding features and see what happens. Looks like that's not the case. Looks like WHOOP figured out that to play in the FDA's sandbox, you need someone who knows the sandbox.
Want a WHOOP too?
Through my link you get the WHOOP hardware free + the first month of membership free. WHOOP rewards me with one month back. Win-win, costs you nothing extra.
Get WHOOP free →